339 patients with advanced knee osteoarthritis undergoing total knee replacement (TKR) were randomized to receive Mako robotic-arm-assisted TKR (rTKR) or conventional TKR (cTKR). The primary outcome of interest was the Forgotten Joint Score (FJS) at 12 months. Secondary outcomes included early postoperative pain, opioid use, Oxford Knee Score (OKS), EuroQol 5-Dimension 5-Level (EQ-5D-5L), complications, radiographic alignment, and health-care costs. Outcomes were assessed during hospitalization and at 3, 6, and 12 months after randomization. Overall, the results of the study revealed no clinically meaningful difference in 12-month FJS between rTKR and cTKR, while secondary patient-reported outcomes and safety were also similar. Although rTKR improved the precision of implant alignment, it increased operating time and costs. rTKR as delivered in routine practice did not provide additional clinical benefit over cTKR during the first postoperative year.
View ACE Report
Your account will be affiliated with
and includes free access to OrthoEvidence
Already have an account? Login now
Part of an association? Click here you may have full access!
If an account exists with the provided email address, a password reset email will be sent to you. If you don't see an email, please check your spam or junk folder.
For further assistance, contact our support team.